ribonucleas
rnase
larg
number
enzym
gather
differ
bacteri
eukaryot
superfamili
bovin
pancreat
rnase
bovin
semin
bsrnase
human
pancreat
rnase
angiogenin
rnase
amphibian
onconas
belong
pancreat
type
superfamili
binas
barnas
bacteri
rnase
famili
physiolog
condit
rnase
secret
extracellular
space
counteract
undesir
effect
extracellular
rna
becom
protect
infect
instead
enter
cell
rnase
digest
intracellular
rna
becom
cytotox
advantag
effect
malign
cell
biolog
activ
investig
either
vitro
toward
number
differ
cancer
cell
line
case
vivo
test
potenti
therapeut
use
howev
immunogen
undesir
effect
sometim
associ
action
nevertheless
use
rnase
therapi
remain
appeal
strategi
still
incur
tumor
mesothelioma
melanoma
pancreat
cancer
rnase
inhibitor
ri
present
insid
almost
cell
efficaci
sentri
counteract
ribonucleolyt
action
intracellular
rna
form
tight
irrevers
enzymat
inact
complex
mani
monomer
rnase
therefor
dimer
multimer
could
repres
use
strategi
rnase
exert
remark
cytotox
activ
evad
interact
ri
steric
hindranc
inde
major
mention
rnase
heterodimer
antibodi
deriv
even
homodimer
multimer
spontan
artifici
occur
weak
interact
upon
introduc
coval
bond
immunornas
particular
fusion
protein
repres
promis
drug
combin
high
target
specif
easi
deliveri
tumor
result
concern
biolog
featur
mani
rnase
report
literatur
describ
discuss
review
furthermor
activ
display
rnase
form
oligomer
complex
mechan
drive
toward
supramolecular
structur
biolog
rebound
connect
analyz
aspect
offer
perspect
suggest
possibl
efficaci
therapeut
applic
rnase
oligomer
deriv
could
contemporarili
lack
strongli
reduc
immunogen
undesir
sideeffect
ribonucleas
rnase
form
larg
group
bacteri
eukaryot
enzym
deepli
studi
last
year
rnase
catalyz
hydrolysi
varieti
differ
rna
substrat
logic
suitabl
classif
famili
may
easi
immedi
furthermor
cell
contain
larg
number
distinct
rnase
approach
mani
twenti
member
often
character
differ
sometim
overlap
substrat
specif
howev
notwithstand
complex
use
classif
may
descend
differenti
intracellular
rnase
one
secret
extracellular
fluid
also
call
secretori
rnase
focu
attent
group
secretori
rnase
includ
sinc
increas
number
member
discov
character
classifi
pancreatictyp
rnase
definit
origin
bovin
pancreat
rnase
kda
aa
residu
enzym
studi
rnase
past
alreadi
year
old
review
rain
still
remain
exhaust
mileston
describ
mani
aspect
rnase
especi
catalyt
activ
recent
rnase
pancreatictyp
superfamili
prototyp
refer
sometim
bovin
variant
human
pancreat
rnase
call
hprnase
rnase
variant
express
pancrea
almost
tissu
display
highli
similar
ident
sequenc
rnase
although
former
basic
latter
rnase
rnase
variabl
glycosyl
expens
asn
residu
especi
rnase
prone
suffer
modif
former
besid
two
member
import
rnase
includ
mention
superfamili
although
secret
pancrea
deserv
notic
cytotox
bovin
semin
rnase
bsrnase
uniqu
nativ
dimer
member
superfamili
also
rnase
angiogenin
ang
ang
aa
residu
long
call
activ
role
new
vessel
format
exert
ribonucleolyt
activ
trna
well
rnase
belong
nonmammalian
speci
bird
amphibian
also
known
among
rnase
studi
aa
residu
amphinas
smallest
variant
call
ranpirnas
protein
form
aa
residu
latter
variant
commonli
call
onconas
onc
remark
antitumor
activ
exert
mani
cancer
type
although
mammalian
amphinas
onc
includ
pancreatictyp
superfamili
structur
homolog
pancreat
rnase
character
sequenc
ident
henc
main
gener
requisit
necessari
belong
pancreatictyp
superfamili
conserv
catalyt
triad
form
one
ly
two
residu
rnase
ii
elev
homolog
fold
resembl
vlike
kidneylik
shape
rnase
iii
distribut
basic
charg
residu
almost
total
locat
proxim
activ
site
region
allow
efficaci
accommod
neg
charg
rna
polym
rnase
activ
site
caviti
therefor
mani
mention
basic
residu
consid
subsit
crucial
optim
catalysi
sometim
consid
even
secondari
activ
site
recent
report
human
rnase
aspect
acquir
increas
import
recal
rnase
often
interact
polymer
substrat
short
oligonucleotid
also
point
arnold
quit
interest
review
princip
featur
mammalian
amphibian
rnase
exhaust
compar
eight
secretori
rnase
variant
number
character
today
human
alreadi
mention
pancreat
rnase
express
tissu
particularli
abund
endotheli
cell
biolog
activ
featur
devot
control
extracellular
rna
exrna
content
biolog
fluid
report
rnase
instead
highli
basic
eosinophil
secretori
variant
reciproc
share
ident
rnase
respect
pancreatictyp
superfamili
basic
residu
randomli
locat
howev
aa
residu
long
rnase
display
activ
yeast
rna
compar
one
pancreat
enzym
rnase
eosinophilderiv
neurotoxin
edn
addit
present
mani
organ
fluid
ednrnas
elicit
purkinj
cell
death
releas
cerebellum
exert
crucial
physiolog
action
take
part
innat
host
defens
releas
eosinophil
granul
respons
inflammatori
mediat
support
immunemodulatori
role
particular
cytokin
induc
rnase
also
rnase
secret
via
pathway
addit
rnase
display
chemoattract
effect
elicit
dendrit
cell
matur
activ
also
exert
activ
respiratori
syncyti
human
immunodefici
virus
inde
viru
infect
trigger
eosinophil
rnase
releas
tolllik
receptor
signal
pathway
differ
edn
aa
residu
rnase
eosinophilspecif
also
name
eosinophil
cation
protein
ecp
ecp
peculiar
rnase
world
fact
although
less
neurotox
edn
exert
remark
bactericid
effect
promot
agglutin
bacteria
cell
cytotox
also
catalyt
activ
nil
sever
inflammatori
stimuli
trigger
ecp
releas
serum
concentr
use
biomark
variou
inflammatori
diseas
includ
asthma
allerg
rhiniti
dermat
bowel
diseas
furthermor
differ
wtrnase
ecp
form
amyloidlik
fibril
acid
ph
rnase
aa
residu
today
least
studi
human
rnase
variant
although
ubiquit
express
suggest
import
physiolog
role
highli
select
uridin
rna
site
cleavag
similarli
rnase
rnase
display
angiogen
activ
consequ
protect
neuron
degener
promot
angiogenesi
neurogenesi
neuron
surviv
stress
importantli
polymorph
recent
pathogen
mutat
associ
rnase
amyotroph
later
sclerosi
al
develop
alreadi
mention
aa
rnase
ang
consid
oldest
pancreat
type
rnase
member
display
three
instead
four
pair
cystein
respect
rnase
ribonucleolyt
activ
although
low
mandatori
angiogenet
action
local
also
import
somehow
contradictori
biolog
function
exert
differ
cell
compart
condit
fact
extracellular
space
ang
trigger
growth
signal
pathway
akt
activ
upon
bind
receptor
howev
wellcharacter
yet
insid
cell
instead
high
affin
bind
cellular
ribonucleas
inhibitor
ri
switch
catalyt
biolog
activ
howev
ang
molecul
sequest
ri
inde
phosphoryl
one
escap
ri
enter
nucleu
accumul
nucleolu
ang
stimul
ribosom
transcript
exert
angiogenet
activ
cancer
cell
increas
rrna
product
angiogenesi
definit
enhanc
cell
growth
tumor
progress
therefor
ang
inhibit
one
hand
counteract
tumor
growth
time
could
also
promot
neuron
damag
fact
rnase
mani
loss
function
ang
mutant
associ
al
andor
parkinson
diseas
contrast
nuclear
activ
ang
address
stress
granul
split
trna
fragment
trf
case
ang
perform
differ
function
rna
interferencelik
mechan
inde
ang
known
trigger
format
cytotox
trf
speci
upon
knockdown
ri
consequ
induc
cell
death
effect
prevail
ang
angiogenet
action
conclus
differ
condit
ang
induc
either
cell
death
surviv
aa
residu
long
rnase
character
two
catalyt
center
ubiquit
distribut
includ
neutrophil
monocyt
rnase
thought
exert
activ
role
inflamm
level
increas
urinari
tract
infect
antimicrobi
properti
variant
carri
induc
bacteria
agglutin
furthermor
rnase
well
rnase
highli
effect
mycobacterium
aurum
induc
autophagi
process
infect
macrophag
final
rnase
form
aa
residu
respect
display
high
structur
similar
although
former
express
skin
also
epitheli
tissu
organ
induc
growth
factor
cytokin
bacteri
product
convers
rnase
princip
express
placenta
also
spleen
lung
testi
impli
presenc
defens
system
pathogen
cross
placenta
target
fetu
importantli
underlin
import
featur
eight
human
variant
welldescrib
two
review
provid
sorrentino
recent
group
lead
boix
report
peculiar
remark
biolog
activ
exert
mani
rnase
would
seem
first
directli
relat
abil
hydrolyz
rna
instead
alreadi
mention
bsrnase
ang
onc
amphinas
least
minim
ribonucleolyt
activ
mandatori
express
biolog
action
among
cytotox
malign
cell
emerg
sinc
bsrnase
discov
also
immunosuppress
embryotox
aspermatogen
interestingli
histori
find
relat
antitumor
action
mani
rnase
welldescrib
matousek
consid
structur
function
properti
report
four
bacteri
rnase
belong
rnase
microbi
superfamili
follow
barnas
bacillu
amyloliquefacien
binas
b
pimulu
balifas
b
licheniformi
balnas
b
altitudini
barnas
found
bound
inhibitor
barstar
dimer
contemporarili
form
dibarnas
immunoderiv
exert
remark
antitumor
activ
mani
cancer
cell
type
binas
nativ
dimer
possess
remark
cytotox
antivir
activ
transform
myeloid
cell
fibroblast
also
siha
cervix
human
papilloma
virusinfect
carcinoma
cell
without
induc
immun
respons
addit
molecular
mechan
carri
without
catalyt
degrad
rna
suggest
ilinskaya
et
al
explain
binas
antitumor
effect
inde
binas
report
interact
kra
stabil
inact
gdpbound
conform
ra
therebi
inhibit
mapkerk
signal
balifas
stabl
variant
group
nativ
dimer
combin
part
binas
barnas
featur
balnas
almost
ident
binas
except
mutat
residu
howev
biolog
activ
well
one
balifas
investig
enough
yet
rnase
belong
famili
whose
human
variant
name
also
deserv
mention
remark
biolog
activ
found
bacteria
plant
virus
also
anim
exert
enzymat
activ
ph
valu
around
lower
neutral
ph
around
major
rnase
activ
secret
damag
tissu
exhibit
chemotact
activ
initi
immun
respons
fact
recombin
inject
induc
fibroplasia
connect
tissu
remodel
recruit
infiltr
cell
express
macrophag
marker
furthermor
human
lack
carri
mutat
suffer
neurolog
disord
even
misfunct
immun
system
ca
activ
rnase
present
almost
mammalian
cell
type
process
rna
matur
form
regul
rna
turnov
metabol
properli
tune
associ
cellular
process
addit
rnase
also
work
alarm
sentinel
block
sever
cellular
dysfunct
inde
act
immun
regul
agent
induc
tissu
repair
remodel
epitheli
barrier
protect
bodi
fluid
steril
exrna
clearanc
regard
latter
aspect
exrna
promot
activ
proteas
trigger
blood
coagul
factor
xi
xii
rnase
pretreat
delay
occlus
thrombi
format
moreov
exrna
mediat
endotheli
brain
permeabl
rnase
treatment
reduc
vessel
occlus
prevent
brain
edema
furthermor
vivo
administr
rnase
reduc
patholog
paramet
characterist
ischemiareperfus
injuri
thu
improv
function
myocardi
recoveri
final
consid
exrna
abl
increas
inflamm
stimul
leukocyt
adhes
transmigr
mobil
proinflammatori
cytokin
secretori
rnase
becom
crucial
modul
physiolog
cell
function
act
natur
exrna
scaveng
moreov
recent
discov
exrna
especi
noncod
one
secret
tumor
cell
act
signal
modifi
cell
microenviron
favor
tumor
progress
metastasi
format
largest
part
exrna
releas
bodi
fluid
encapsul
insid
extracellular
vesicl
exosom
associ
high
densiti
lipoprotein
thu
even
vesicl
exrna
protect
secretori
rnase
abl
cross
membran
report
hereinaft
thu
exert
antitumor
activ
counteract
metastat
process
also
extracellular
level
gener
human
secretori
rnase
also
display
antiinflammatori
antibacteri
antivir
action
induc
immun
respons
larg
amount
dsrna
gener
pathogen
addit
rnase
activ
dna
rna
hybrid
dsrna
rather
ssrna
end
conserv
residu
crucial
maintain
full
catalyt
activ
duplex
rna
overal
mani
step
forward
perform
comprehens
antimicrobi
effect
ascrib
mani
rnase
promis
result
suggest
potenti
use
despit
classic
antibiot
lose
efficaci
upon
develop
resist
summari
almost
biolog
activ
display
mention
rnase
strictli
depend
ribonucleolyt
activ
vs
ssand
dsrna
necessari
regul
extracellular
rna
level
secret
rnase
endow
relev
biolog
activ
display
action
extracellularli
often
abl
enter
cell
exert
peculiar
activ
intracellular
rna
howev
step
mani
difficulti
inde
emerg
necess
favor
interact
cell
membran
subsequ
releas
cytosol
possibl
evad
ri
issu
extens
describ
next
chapter
togeth
abil
rnase
form
supramolecular
structur
format
oligomer
moieti
becom
fact
advantag
mani
rnase
term
acquir
new
activ
potenti
preexist
one
well
minim
undesir
interact
also
reduc
advers
side
effect
vivo
main
obstacl
extracellular
rnase
exert
antitumor
action
repres
possibl
difficulti
cellularli
intern
occur
endocytosi
fruit
interact
cell
membran
occur
howev
possibl
onc
intern
mediat
receptor
propos
debat
well
sundlass
et
al
compar
abil
rnase
rnase
onc
interact
lipid
bilay
reveal
either
electrostat
forc
specif
interact
determin
time
spent
rnase
near
cell
surfac
critic
intern
addit
notomista
et
al
demonstr
cytotox
nativ
engin
dimer
rnase
strongli
affect
membran
aggreg
fluiditi
fusion
consid
desir
biolog
activ
rnase
select
cytotox
malign
cell
cell
possess
neg
charg
membran
normal
one
basic
rnase
like
import
featur
necessari
win
challeng
howev
basic
net
charg
per
se
enough
rnase
intern
cell
fact
specif
orient
rnase
molecul
becom
crucial
success
approach
cell
membran
therefor
select
favor
rnasemembran
interact
patch
object
mani
studi
focus
especi
onc
bsrnase
also
rnase
rnase
particular
nativ
dimer
bsrnase
assum
advantag
orient
intern
face
ntermini
toward
cell
membran
structur
bsrnase
show
ntermini
actual
adopt
orient
furthermor
mutant
endow
addit
cation
keyresidu
orient
direct
nterminu
interact
membran
strongli
even
cytotox
wild
type
henc
orient
basic
charg
could
also
affect
cytotox
potenti
rnase
oligom
studi
show
instead
bsrnase
approach
membran
differ
onc
similarli
rnase
rnase
rnase
turn
show
monomer
variant
accompani
highest
propens
intern
cell
moreov
rnase
cellular
intern
consid
also
frontier
immunolog
wwwfrontiersinorg
residuespecif
fact
wtonc
less
effici
intern
call
rmutant
lysin
residu
two
crucial
catalysi
replac
arginin
underlin
howev
rnase
basic
net
charg
randomli
increas
advantag
repres
favor
intern
may
counteract
cell
rnase
affin
increas
toward
neg
charg
ri
final
interestingli
note
bsrnase
high
bind
affin
also
toward
extracellular
matrix
ecm
sinc
cytotox
cho
cell
grown
suspens
quit
lower
one
exert
vs
adher
cell
subtyp
enter
cell
rnase
must
overpass
obstacl
exert
activ
issu
wellpres
anoth
review
contribut
arnold
cytotox
potenc
differ
rnase
certainli
due
optim
cell
membran
interact
endocyt
intern
also
resist
proteolyt
degrad
endosomeslysosomestran
golgi
fruit
releas
cytosol
discord
data
present
literatur
regard
actual
intern
mechan
rnase
fact
haigi
rain
demonstr
onc
rnase
variant
intern
earli
endosom
hela
cell
clathrinand
caveolaeindepend
mechan
rodriguez
et
al
indic
jurkat
cell
endocytos
onc
dynamindepend
rout
presum
follow
endocyt
pathway
howev
controversi
data
suggest
rnase
go
divers
rout
cross
membran
differ
cell
line
rnase
rout
toward
final
cytosol
destin
first
step
deliveri
earli
endosom
instead
featur
subsequ
intracellular
rout
step
complet
understood
far
bsrnase
intern
endosom
vesicl
either
normal
malign
cell
latter
one
cytotox
reach
golgi
apparatu
ie
intracellular
station
cytosol
deliveri
addit
bsrnase
variant
character
cterminu
engin
keysequ
use
local
endoplasm
reticulum
cytotox
unabl
releas
cytosol
elicit
antitumor
activ
furthermor
two
rnase
mutant
design
evad
ri
fuse
scfv
fragment
human
antigen
deliv
leukem
cell
abl
bind
cell
surfac
intern
cytotox
deliv
lysosom
compart
degrad
instead
cytotox
restor
intern
transfect
contrast
human
fusion
protein
intern
cell
direct
transfer
endosom
cytosol
demonstr
case
cell
death
occur
apoptosi
ic
nm
recent
interest
strategi
intracellularli
intern
rnase
propos
three
cation
aminereact
linker
attach
rnase
stabil
conjug
phdepend
therefor
endocyt
vesicl
acid
environ
led
releas
high
cytosol
amount
rnase
make
concentr
high
enough
overcom
ri
bind
capac
becom
cytotox
howev
rnase
distinct
alway
success
outcom
sever
cellular
organel
endosom
lysosom
er
transgolgi
network
thu
mani
studi
perform
unveil
intracellular
rout
extracellular
rnase
intern
endocytosi
rel
result
indic
divers
rnase
onc
bsrnase
well
rnase
rnase
ang
follow
differ
cellular
pathway
within
one
anoth
describ
propos
sever
report
final
rememb
capabl
exert
activ
nucleu
crucial
rnase
inde
angrnas
need
enzymat
activ
also
enter
nucleu
exert
fundament
angiogen
activ
normal
cancer
cell
ang
exploit
surfac
loop
involv
argtriplet
whose
replac
provok
block
either
nuclear
import
angiogenesi
notabl
insert
nuclear
local
sequenc
nl
involv
arg
residu
locat
loop
present
rnase
rnase
variant
make
abl
enter
nucleu
exert
angiogenet
cytotox
activ
respect
evid
suggest
differ
rnase
locat
compart
address
action
differ
rna
target
trigger
divers
biolog
reaction
consid
human
natur
rnase
nuclear
activ
becom
advantag
term
obtain
cytotox
variant
devoid
immunogen
alreadi
mention
huge
obstacl
rnase
actual
activ
cell
repres
interact
ri
kda
protein
firstli
extract
rat
liver
human
variant
isol
placenta
interact
rnase
firstli
detect
ang
ri
neg
charg
horseshoeshap
leucinerich
macromolecul
ubiquit
express
almost
cell
ri
consid
mani
year
present
cell
cytosol
recent
presenc
detect
also
mitochondria
nuclei
ri
biolog
function
complet
clarifi
consid
numer
cystein
residu
contribut
redox
cellular
homeostasi
state
ri
form
tight
complex
rnase
rnase
ang
edn
ri
interact
also
rnase
highli
conserv
cell
mani
mammalian
speci
present
also
nonmammalian
one
rnaseri
complex
character
far
dissoci
k
valu
fall
picoto
femtomolar
rang
rnaseri
complex
structur
explain
rnase
activ
inhibit
enzym
moieti
cage
insid
ri
caviti
ang
steric
evad
cytosol
interact
ri
undergo
phosphoryl
serthr
residu
crucial
ri
bind
way
intern
nucleu
exert
angiogenet
activ
instead
onc
except
evad
extens
lower
affin
ri
devoid
keyresidu
allow
rnase
interact
necessari
form
tight
rnaseri
complex
reason
onc
actual
display
remark
cytotox
henc
sitespecif
mutagenesi
approach
made
also
rnase
mammalian
origin
capabl
evad
ri
exert
cytotox
potenti
could
consid
complet
true
rememb
mani
year
ago
ledoux
found
wtrnase
activ
tumor
either
vitro
vivo
howev
must
underlin
high
rnase
dose
mgmous
concentr
lower
mgml
cell
cultur
medium
use
case
therefor
even
rnase
molecul
enter
cell
dose
certainli
overpass
cytosol
ri
concentr
henc
exceed
rnase
amount
free
exploit
ri
satur
exert
cytotox
activ
line
report
liu
et
al
recal
beyond
onc
mammalian
bsrnase
also
cytotox
inde
nativ
dimer
steric
evad
ri
wellknown
fact
monomer
bsrnase
deriv
although
retain
ribonucleolyt
activ
definit
lose
cytotox
sequest
ri
final
anoth
way
make
potenti
activ
rnase
actual
cytotox
could
silenc
ri
action
even
though
sensit
ri
uniqu
factor
determin
cell
cytotox
point
conflict
result
support
opposit
argument
certainli
demonstr
noncytotox
rnase
unabl
affect
hela
cell
viabil
also
depriv
ri
contrari
noncoval
artifici
dimer
rnase
although
risensit
found
cytotox
malign
leukemia
cell
line
concentr
even
definit
inact
pancreat
cancer
cell
report
envisag
rnase
induc
oligomer
thu
bulkier
nativ
monom
would
augment
charg
densiti
enzym
moieti
help
intern
tumor
cell
furthermor
increas
steric
hindranc
would
help
evad
ri
interact
bsrnase
strategi
correl
present
discuss
next
chapter
step
necessari
exert
biolog
action
could
repres
huge
obstacl
rnase
henc
point
mutat
well
posttransduct
also
vitro
modif
might
help
overcom
barrier
moreov
context
control
induct
protein
selfassoci
lead
natur
artifici
rnase
oligom
may
repres
fruit
strategi
promot
convers
underw
organ
obtain
rnase
deriv
exert
remark
biolog
activ
line
argument
rnase
gener
protein
oligomer
occur
spontan
induc
also
cell
environ
vivo
context
oligomer
provok
artifici
vitro
obtain
control
plethora
product
character
light
desir
goal
artifici
oligomer
induc
form
coval
link
deriv
upon
reaction
protein
bifunct
multifunct
crosslink
way
stabl
heteroor
homooligom
produc
concomit
modif
one
aa
residu
dimer
oligomer
obtain
also
condit
favor
spontan
protein
selfassoci
crosslink
subunit
protein
occur
spontan
respons
cell
signal
membran
protein
cell
factor
upon
undergo
photochem
event
phosphoryl
apoholo
transit
even
posttransduct
modif
date
within
mammalian
rnase
bsrnase
known
nativ
homodim
thank
format
two
antiparallel
disulfid
involv
residu
one
subunit
viceversa
two
residu
instead
differ
cystein
known
rnase
therefor
mani
strategi
follow
induc
rnase
dimer
oligomer
forc
react
appropri
crosslink
reagent
taken
account
howev
chemic
modif
somehow
modifi
properti
nativ
rnase
thu
might
neg
affect
biolog
activ
henc
balanc
desir
modif
excess
unwant
affect
nativ
properti
mandatori
obtain
deriv
accompani
fruit
enzymat
biolog
activ
rnase
artifici
associ
exploit
crosslink
reaction
variou
bifunct
multifunct
reagent
use
crosslink
mention
involv
especi
rnase
rnase
accompani
descript
posit
neg
rebound
rel
catalyt
andor
antitumor
activ
product
obtain
diimidoest
dialdehyd
figur
ie
bifunct
crosslink
react
ly
residu
protein
reagent
display
two
termin
reactiv
group
separ
variabl
number
unreact
methylen
ch
n
spacer
concern
rnase
reaction
dimethyladipimid
dimethylpimelimid
especi
dimethylsuberimid
ie
reagent
display
spacer
differ
n
valu
figur
allow
differ
size
stabl
dimer
oligom
form
often
accompani
higher
enzymat
activ
nativ
monom
crosslink
advantag
produc
protein
homooligom
altern
cation
thu
cytotox
complex
ad
bulki
amin
polyamin
coval
mediat
diimidoest
crosslink
revers
spacer
contain
disulfid
bond
becom
scissil
cytosol
reduc
environ
reach
reactiv
ly
nucleophil
residu
two
imid
crosslink
figur
effici
control
dialdehyd
like
glutaraldehyd
figur
allow
process
protein
maintain
overal
charg
unmodifi
import
undesir
limit
repres
suscept
crosslink
activ
site
ly
residu
unless
protect
phosphat
thu
drive
toward
percentag
inact
product
howev
upon
properli
tune
reaction
condit
amount
rnase
dimer
character
enzymat
cytotox
activ
definit
higher
nativ
rnase
produc
beyond
yield
activ
rnase
dimer
dimethylsuberimid
figur
allow
format
amount
coval
link
trimer
trace
higherord
oligom
character
relev
cytotox
activ
cell
uteru
cervix
squamou
carcinoma
beyond
polyamin
rnase
complex
also
differ
size
peg
moieti
inde
rnase
pegderiv
known
inhibit
tumor
growth
mice
pegconjug
rnase
oligom
cytotox
transplant
melanoma
mice
well
ii
obtain
activ
rnase
oligom
bifunct
nsubstitut
maleimid
deriv
display
spacer
variabl
length
certainli
use
reagent
induc
crosslink
free
cy
sulfhydryl
maleimid
form
revers
adduct
spacer
contain
scissil
disulfid
bond
presenc
protein
free
sh
group
mandatori
make
crosslink
product
unfortun
rnase
display
free
cystein
consequ
reaction
occur
upon
introduc
free
cy
residu
upon
mutagenesi
maleimid
also
trifunct
figur
even
way
produc
coval
link
trimer
andor
larger
oligom
inde
group
led
rain
succeed
obtain
mani
trimer
coupl
cysteinefre
rnase
rnase
bsrnase
onc
mutant
tri
nmaleimidoethyl
amin
rnase
except
onc
mani
mutant
display
cy
spite
residu
produc
mutat
wild
type
requir
residu
allow
proper
accommod
rnase
molecul
ri
caviti
form
alreadi
mention
tight
rnaseri
complex
instead
sinc
onc
lack
mutant
produc
allow
format
trimer
upon
crosslink
protein
trifunct
maleimid
rnase
trimer
adduct
onc
one
increas
antitumor
activ
either
vitro
mice
respect
inact
less
activ
wtmonom
trimer
show
instead
less
cytotox
definit
activ
wtonc
monom
howev
advantag
obtain
bulki
onc
trimer
deriv
resid
probabl
steric
inabl
filter
kidney
glomeruli
consequ
increas
circul
halflif
inde
may
repres
crucial
advantag
perspect
use
product
cancer
therapi
consid
monomer
wtonc
display
renal
toxic
vivo
although
undesir
effect
revers
upon
discontinu
treatment
iii
zerolength
dimer
rnase
dimer
oligom
form
also
upon
interact
carbodiimid
r
nccr
ie
dehydr
molecul
n
n
ethylcarbodiimid
edc
induc
format
zerolength
dimer
larger
oligom
character
isopeptid
bond
involv
side
chain
amino
group
ly
carboxyl
group
asp
glu
residu
reagent
coval
fix
previous
form
oligomer
aggreg
contemporarili
avoid
unwant
charg
modif
insert
chemic
protein
complex
supramolecular
rnase
zerolength
adduct
produc
also
heat
protein
c
vacuum
method
allow
rnase
form
novel
isopeptid
bond
ly
glu
asp
residu
upon
induc
heatvacuum
dehydr
condens
reaction
affect
princip
exclus
rnase
residu
howev
deriv
show
definit
reduc
enzymat
activ
inact
cancer
cell
unless
strongli
cation
polyspermin
probabl
due
excess
number
least
three
affect
ly
residu
thu
scarc
specif
crosslink
reaction
drive
toward
mixtur
heterogen
product
howev
must
mention
strong
cation
allow
rnase
adduct
gain
cytotox
also
aspermatogen
effect
iv
recent
oligom
produc
also
upon
mix
c
rnase
metal
deriv
commonli
use
chemotherapeut
agent
cisplatin
also
carboor
oxaliplatin
yield
rnase
acisplatin
oligom
remark
increas
cisplatinprotein
ratio
pt
adduct
yield
definit
lower
unfortun
adduct
endow
scarc
ribonucleolyt
activ
lack
cytotox
princip
catalyt
residu
directli
involv
link
metal
moieti
henc
result
help
explain
cisplatin
andor
similar
adduct
display
reduc
efficaci
undesir
sideeffect
therapi
fact
probabl
affect
protein
rnase
vivo
serum
albumin
well
higher
extent
desir
dna
target
v
rnase
crosslink
also
use
bifunct
crosslink
divinylsulfon
dv
figur
difluorodinitrobenzen
dfdnb
figur
specif
ly
residu
respect
crosslink
lack
spacer
crosslink
residu
resid
close
coval
stabil
preform
oligom
inde
extrem
use
character
mechan
format
noncoval
supramolecular
structur
produc
bsrnase
rnase
onc
use
analyt
purpos
total
inactiv
result
product
involv
activ
site
residu
asymmetr
bifunct
reagent
certainli
use
overcom
lack
proteinfre
cy
residu
fact
coval
link
antibodi
part
lightheavi
chain
protein
protein
domain
toxin
whatev
display
biolog
interest
figur
one
side
maleimid
succinimid
sometim
display
dithioderiv
spacer
combin
terminu
imidoest
dion
thion
one
reagent
often
use
achiev
coval
heterodimer
oxycarbonyl
phenyl
mb
mani
other
avail
test
protein
differ
rnase
asymmetr
reagent
use
form
activ
heteroadduct
involv
rnase
well
fact
onc
display
remark
antitumor
activ
breast
cancer
brain
glioma
vitro
mice
upon
chemic
conjug
altern
chlorotoxin
strong
specif
antitumor
effect
exert
monoclon
antibodi
coval
link
onc
significantli
increas
life
span
anim
display
nonhodgkin
bcell
lymphoma
chemic
crosslink
egfrnas
immunornas
tumoricid
adduct
produc
sinc
rnase
rnase
list
mention
heterocomplex
report
tabl
togeth
one
obtain
immunofus
product
discuss
hereaft
ii
altern
protein
engin
permit
clone
express
fusion
homoor
heterofus
dimer
well
fusion
immunoprotein
conjug
figur
cdna
encod
desir
rnase
fuse
gene
heavi
light
singlechain
antibodi
strategi
follow
diabodi
figur
j
noncoval
dimer
singl
chain
antibodi
fragment
scfv
consist
variabl
region
heavi
light
chain
v
h
v
l
connect
small
peptid
linker
desir
addit
peptid
spacer
variou
length
natur
insert
protein
way
natur
coval
link
bind
two
protein
thu
permit
express
complet
adduct
without
requir
subsequ
chemic
modif
case
diabodi
heterodimer
immunernas
adduct
consid
new
entiti
dimer
form
activ
tetram
perform
rnase
onc
figur
j
addit
fusion
protein
compos
two
onc
molecul
fuse
nterminu
v
l
human
antibodi
demonstr
exert
excel
therapeut
efficaci
tumor
either
vitro
vivo
follow
strategi
sever
immunornas
immunotoxinrnas
complex
produc
use
anticanc
agent
also
rnase
instead
group
dalessio
de
lorenzo
chose
coupl
human
rnase
human
figur
result
heterodimer
erbhrnas
adduct
show
definit
cytotox
breast
cancer
induc
less
resist
cardiotox
human
monoclon
antibodi
use
chemotherapeut
agent
furthermor
tetramer
adduct
ie
dimer
heterodim
call
display
even
cytotox
simpl
erbhrnas
adduct
rnase
mutant
design
evad
ri
fuse
scfv
fragment
specif
reduc
viabil
human
leukem
cell
recent
antinucleolin
ncl
immunornas
deriv
display
activ
tripleneg
breast
cancer
respond
treatment
avail
far
proteinfus
techniqu
appli
also
onc
conjug
express
mani
divers
adduct
figur
j
variou
antibodi
fragment
human
serum
albumin
dengu
virusderiv
peptid
recent
ntermin
domain
transferrin
adduct
display
augment
cytotox
vitro
mani
cancer
cell
case
also
mice
augment
activ
often
accompani
lower
propens
undergo
renal
filtrat
indic
result
obtain
membran
mimick
kidney
glomerular
barrier
anoth
crucial
advantag
offer
human
immunornas
microbi
plant
immunotoxin
lack
immunogen
nonspecif
bind
toxic
usual
also
affect
normal
cell
undesir
event
drove
case
even
toward
fatal
event
clinic
trial
inde
de
lorenzo
dalessio
clarifi
immunernas
fusion
protein
nontox
outsid
tumor
cell
also
nonimmunogen
report
tabl
proteinfus
strategi
cancer
use
mani
time
rnase
onc
also
bsrnase
edn
produc
cytotox
deriv
also
immunoang
deriv
produc
effect
cytotox
activ
induc
proper
ang
mutat
differ
linker
introduc
supramolecular
adduct
compar
ang
driven
also
toward
diabodyconjug
dimer
reveal
definit
cytotox
monom
notabl
bacteri
barnas
fungal
rnase
also
derivat
immunotoxin
becom
capabl
intern
cancer
cell
exert
remark
cytotox
activ
final
last
decad
rnase
also
dimer
clone
express
tandem
deriv
way
contrarili
inact
monom
fusionstabil
rnase
deriv
becam
definit
cytotox
human
leukemia
cell
although
reveal
complex
ri
appar
contradictori
result
could
explain
consid
rnase
fusion
moieti
contain
one
activ
site
one
could
orient
way
actual
exert
catalyt
cytotox
action
regard
underlin
structur
fusion
rnase
arnas
deriv
see
figur
contrast
explan
fusionproduc
immunoderiv
mention
list
tabl
mani
review
focus
select
cytotox
action
immunornas
tumor
cell
recent
updat
one
jordaan
et
al
protein
oligomer
also
occur
noncoval
either
natur
artifici
event
inde
nativ
monomer
protein
undergo
dimer
even
larger
oligomer
degre
may
occur
sort
posttransl
event
switch
activ
inact
product
mani
report
analyz
featur
event
involv
mani
protein
follow
paragraph
instead
focu
attent
mechan
mainli
follow
rnase
selfassoci
without
coval
crosslink
ie
one
call
three
dimension
domain
swap
whose
schemat
pictur
shown
figur
noncoval
selfassoci
rnase
mainli
ascrib
mechan
report
tabl
firstli
defin
describ
eisenberg
et
al
affect
mani
protein
mechan
deepli
analyz
also
mani
scientist
partial
violat
anfinsen
dogma
state
aa
sequenc
induc
protein
find
uniqu
fold
fact
flexibl
loop
protein
particular
rnase
residu
instead
adopt
variabl
conform
thu
occupi
one
energi
minimum
allow
domain
link
protein
flexibl
part
adopt
differ
orient
undergo
reciproc
exchang
protom
domain
equival
domain
adjac
subunit
therefor
noncoval
dimer
even
larger
oligom
singl
flexibl
loop
present
form
domain
detach
nativ
monom
reconstitut
nativ
protom
contact
composit
function
unit
fu
oligom
figur
novel
fu
overlap
nativ
monom
except
addit
interfac
whose
conform
depend
particular
protein
isar
absent
nativ
monom
domain
involv
often
protein
ctermini
rnase
oligomer
often
accompani
rnase
increas
enzymat
biolog
activ
moreov
new
properti
absent
nativ
monom
notabl
mechan
share
mani
protein
like
exampl
cytochrom
c
sever
amyloidogen
protein
human
prion
protein
cystatinc
also
microglobulin
selfassoci
except
ecprnas
known
rnase
unabl
undergo
amyloidosi
although
rnase
display
mani
amyloidpron
segment
howev
presenc
proven
ecp
inde
worth
note
residu
insert
incur
rnase
loop
allow
occur
make
capabl
form
amyloidlik
domainswap
fibril
noncoval
aggreg
known
occur
rnase
bsrnase
sinc
affect
catalyt
activ
rna
substrat
involv
alreadi
hypothes
moor
et
al
basi
character
rnase
deriv
rnase
limit
proteolysi
cleav
ntermin
domain
residu
protein
core
rnase
aggreg
therefor
alreadi
ascrib
reciproc
exchang
protein
ntermini
consequ
detach
protein
core
actual
presenc
rnase
detect
bsrnase
mazzarella
et
al
rnase
liu
et
al
next
paragraph
list
discuss
main
featur
domainswap
dimer
oligom
variou
pancreatictyp
rnase
rnase
bsrnase
rnase
recent
also
onc
highlight
relat
biolog
consequ
start
rnase
paragraph
comparison
within
differ
rnase
variant
present
nativ
monomer
kda
rnase
figur
noncoval
selfassoci
interact
substrat
also
oligomer
upon
subject
lyophil
aqueou
acet
acid
solut
thermal
incub
differ
solvent
high
protein
concentr
follow
two
protocol
rnase
produc
domainswap
dimer
trimer
larger
oligom
oligomer
occur
aforement
mechan
involv
nandor
ctermin
domain
protein
thu
produc
differ
rel
amount
cswap
oligom
function
particular
protocol
appli
oligom
separ
cationexchang
chromatographi
cswap
speci
endow
higher
basic
charg
exposur
nswap
one
nmr
show
rnase
chiefli
denatur
except
disulphid
acet
acid
refold
properli
except
flexibl
loop
lyophil
redissolv
benign
buffer
phosphat
permit
format
mani
differ
rnase
oligom
trace
tetradecam
structur
rnase
nand
cterminiswap
dimer
call
ndimer
n
cdimer
c
respect
cyclic
cswap
trimer
c
solv
figur
f
addit
model
base
experiment
data
built
n
cswappedtrim
ie
display
swap
enzym
termini
nc
figur
mani
n
cswap
tetram
figur
larger
multim
abund
speci
detect
certainli
cdimer
approach
yield
amount
deriv
thermal
incub
lower
dv
dfdnb
figur
f
crosslink
analysi
confirm
protein
selfassoci
involv
rnase
nandor
ctermini
oligom
hexam
analyz
structur
determin
govern
rnase
oligomer
deepli
investig
detail
polar
rnase
nand
ctermini
affect
swap
propens
oligom
stabil
either
reduc
condit
deamid
event
affect
mani
asn
residu
reduc
tendenc
rnase
aggreg
importantli
ci
configur
peptid
bond
present
loop
preced
cterminu
rnase
rnase
also
bsrnase
hinder
tendenc
terminu
swap
consequ
harsh
condit
requir
switch
mention
bond
ci
tran
let
format
remark
amount
rnase
cdimer
context
quit
surpris
rnase
cdimer
detect
endoplasm
reticulum
pancreat
exocrin
cell
although
subsequ
dimer
fail
secret
also
glycosil
hinder
rnase
selfassoci
demonstr
nglycosil
rnase
form
call
rnase
b
mani
report
indic
actual
reciproc
f
crystal
structur
total
cswap
cyclic
trimer
c
pdb
g
n
c
ntetram
linear
model
h
c
n
ctetram
linear
model
n
c
ntetram
bent
model
j
n
c
c
ctetram
model
influenc
nand
ctermini
swap
behavior
line
rnase
inde
deriv
dimer
upon
acid
lyophil
less
rnase
obvious
swap
cterminu
rnase
oligom
increas
enzymat
activ
dsrna
substrat
vs
dna
rna
hybrid
respect
nativ
monom
increas
directli
proport
size
oligom
moreov
within
type
oligom
ie
within
n
vs
c
nc
vs
c
etc
see
figur
highest
enzymat
activ
display
speci
contain
cswap
nswap
former
speci
expos
higher
basic
charg
densiti
latter
one
antitumor
activ
oligom
measur
obtain
controversi
result
relev
activ
alway
increas
basic
charg
densiti
oligom
display
leukemia
cell
vitro
vivo
human
melanoma
cell
transplant
nude
mice
moreov
similar
vivo
experi
antitumor
activ
slightli
increas
rnase
oligom
conjug
peg
case
free
pegconjug
rnase
oligom
devoid
embryotox
activ
convers
rnase
oligom
activ
two
human
pancreat
tumor
cell
line
howev
actual
antitumor
activ
rnase
oligom
debat
two
rnase
dimer
known
interact
ri
although
stoichiometri
like
aforement
tandem
rnase
arnas
fusion
dimer
figur
display
cytotox
must
underlin
howev
wang
et
al
recent
report
rnase
differ
rnase
ang
induc
cell
prolifer
ascrib
extracellular
rnase
interact
epiderm
growth
factor
receptor
egfr
way
counteract
cytotox
well
henc
report
evalu
actual
antitumor
potenti
rnase
speci
certainli
deserv
investig
mention
bsrnase
uniqu
nativ
homodimer
member
pancreatictyp
rnase
superfamili
two
antiparallel
disulfid
link
residu
one
subunit
viceversa
two
residu
absent
rnase
howev
bsrnase
subunit
compos
aa
residu
display
sequenc
ident
rnase
interestingli
nativ
bsrnase
equilibrium
mixtur
two
isoform
figur
b
one
character
swap
ntermini
repres
panel
b
unswap
name
mm
panel
given
two
interchain
disulfid
permit
dimer
format
equilibrium
deepli
investig
partial
affect
catalyt
activ
enzym
role
intersubunit
disulfid
also
analyz
well
one
hing
loop
connect
nterminu
protein
core
addit
well
residu
shown
influenc
mm
vs
equilibrium
ribonucleolyt
activ
enzym
present
bovin
semin
fluid
firstli
describ
dalessio
leon
respons
agent
activ
discov
bsrnase
definit
basic
activ
dsrna
adduct
rnase
true
also
monomer
enzym
reduct
two
intersubunit
disulfid
thu
confirm
basic
charg
densiti
dimer
natur
per
se
crucial
rnase
activ
dsrna
substrat
moreov
report
bsrnase
exert
remark
antitumor
activ
togeth
immunosuppress
embryotox
aspermatogen
effect
cytotox
select
address
malign
cell
also
human
origin
ascrib
nswap
isoform
neither
mm
wtmonomer
deriv
activ
featur
ascrib
abil
evad
cellular
ri
fact
cytosol
reduc
environ
although
break
two
intersubunit
bsrnase
disulfid
monomer
isoform
whose
dimer
surviv
although
noncoval
dimer
ncd
suffici
time
exert
cytotox
action
unswap
mm
isoform
instead
undergo
monomer
upon
lose
two
mention
disulfid
becom
therefor
suscept
ri
blockag
crystal
structur
mm
figur
b
ncd
isoform
bsrnase
well
monomer
deriv
solv
way
clarifi
crucial
structur
featur
govern
possibl
enzym
exert
biolog
activ
importantli
isoform
vari
conform
upon
lose
intersubunit
disulfid
form
ncd
conserv
residu
allow
ncd
maintain
capabl
evad
ri
see
figur
f
mutat
induc
instead
dramat
variat
reciproc
orient
two
subunit
render
mutat
ncd
variant
inact
becom
suscept
ri
howev
mutant
monomer
bsrnase
deriv
design
evad
ri
exert
higher
cytotox
activ
wildtyp
dimer
well
rnase
bsrnase
easili
undergo
deamid
event
even
quicker
pancreat
variant
howev
acquir
neg
charg
affect
cytotox
addit
mani
effort
perform
increas
rnase
absrnas
similar
make
also
pancreat
variant
endow
antitumor
activ
end
dimer
rnase
variant
built
introduct
mutat
addit
other
reveal
exert
relev
antitumor
action
malign
fibroblast
cytotox
engin
rnase
absrnas
hybrid
display
nswap
dimer
structur
measur
interestingli
bsrnase
also
induc
selfassoci
upon
acet
acid
lyophil
way
tetram
hexam
even
larger
oligom
form
two
differ
tetram
form
swap
ntermini
hypothes
model
mazzarella
et
al
figur
recent
demonstr
bsrnase
swap
also
ctermini
rnase
ctermini
swap
occur
either
nativ
dimer
form
n
c
nswap
tetram
figur
also
involv
bsrnase
monomer
deriv
produc
cswap
dimer
structur
similar
ident
rnase
c
importantli
bsrnase
oligom
also
display
enzymat
cytotox
activ
higher
nativ
dimer
activ
increas
size
oligom
consequ
basic
charg
densiti
regard
mani
structur
enzymat
antitumor
featur
rnase
bsrnase
oligomer
speci
compar
discuss
human
pancreat
hp
rnase
figur
nativ
monomer
aa
residu
long
display
cterminu
elong
four
residu
respect
bovin
homolog
rnase
basic
elong
affect
rnase
stabil
reduc
slightli
enzymat
activ
moreov
variant
definit
activ
rnase
vs
dsrna
substrat
reach
maxim
valu
ph
ph
close
one
blood
definit
higher
valu
rnase
exert
maxim
activ
therefor
consid
high
basic
nativ
state
rnase
mutat
insert
well
rnase
two
cystein
residu
make
dimer
similarli
bsrnase
mutant
name
hhprnase
display
remark
antitumor
activ
sever
type
malign
cell
line
among
cell
neuroblastoma
rhabdomyosarcoma
show
highest
sensibl
inde
rnase
variant
display
coupl
plu
mutat
call
exert
quit
high
antitumor
activ
human
thyroid
carcinomaderiv
cell
line
vivo
malign
cell
transplant
nude
mice
cytotox
exert
swap
unswap
isom
contrarili
bsrnase
result
ascrib
stabil
effect
hing
loop
side
chain
term
maintain
two
residu
close
recent
differ
cytotox
dimer
mutant
engin
evad
ri
display
exert
relev
cytotox
activ
well
rnase
mutant
abl
swap
ntermini
produc
fiveresidu
mutant
make
rnase
ntermin
edg
ident
bsrnase
display
higher
stabil
wild
type
moreov
addit
mutat
introduc
variant
allow
rnase
spontan
dimer
thank
format
four
novel
intersubunit
hbond
figur
addit
mutat
permit
also
stack
interact
protom
gain
similarli
occur
rnase
n
henc
rnase
nswap
dimer
call
combin
structur
determin
bsrnase
five
mutat
nterminu
crucial
role
detect
rnase
ndimer
howev
structur
dimer
quit
differ
bsrnase
isoform
disulfid
absent
delet
suffer
loop
connect
nterminu
protein
core
de
de
hprnase
induc
spontan
format
stabl
dimer
form
domain
swap
ntermini
figur
confirm
dv
crosslink
interestingli
de
hprnase
mutant
recent
discov
form
supramolecular
structur
resembl
amyloidlik
rodshap
fibril
structur
featur
mani
dimer
rnase
variant
deepli
analyz
antitumor
activ
investig
far
extract
rana
pipien
oocyt
onc
uniqu
pancreatictyp
rnase
known
remark
cytotox
stabl
nativ
monomer
form
figur
togeth
less
investig
also
amphibian
amphinas
variant
although
smallest
aa
mw
kda
pancreatictyp
rnase
also
highli
catalyt
activ
onc
display
catalyt
triad
catalyt
subsit
similar
rnase
one
well
furthermor
beyond
antitumor
effect
onc
display
promin
antivir
action
upregul
factor
inhibit
viral
genom
replic
onc
penetr
cancer
cell
high
basic
favor
interact
sialic
acid
moieti
present
malign
cell
membran
crucial
step
onc
evad
ri
lack
key
residu
necessari
form
tight
complex
inhibitor
onc
attack
trna
well
substrat
mirna
exert
cytotox
action
thu
first
glanc
would
seem
unnecessari
produc
onc
supramolecular
structur
design
anticanc
therapi
fact
mani
posit
result
regist
monomer
wtonc
vitro
vivo
sever
still
incur
tumor
like
pleural
mesothelioma
human
lung
glioma
pancrea
melanoma
howev
although
revers
renal
toxic
onc
discov
upon
clinic
trial
partial
cool
initi
enthusiasm
somehow
alert
find
way
enlarg
dimens
onc
moieti
make
filtrat
glomerular
barrier
difficult
increas
circul
halflif
time
consequ
mani
fusion
immuneonc
deriv
success
built
report
previou
paragraph
tabl
notwithstand
remark
stabil
c
onc
recent
discov
form
nswap
dimer
upon
lyophil
acet
acid
figur
notabl
dimer
display
cytotox
pancreat
cancer
cell
correspond
nativ
onc
monom
unfortun
onc
swap
nterminu
cterminu
lock
disulfid
involv
termin
residu
imposs
swap
one
domain
definit
reduc
protein
selfassoci
propens
gener
certainli
case
onc
moreov
onc
variant
built
unlock
cterminu
found
less
stabl
nativ
enzym
suggest
neg
influenc
free
onc
cterminu
stabil
nswap
dimer
confirm
also
onc
reciproc
influenc
nand
ctermini
event
involv
rnase
consequ
uniqu
way
known
date
obtain
larg
onc
homooligom
use
escap
renal
filtrat
use
aforement
trifunct
maleimid
produc
coval
deriv
see
figur
howev
final
mention
recent
studi
exploit
onc
rnase
featur
build
chimera
abl
remark
augment
tendenc
latter
mammalian
enzym
undergo
oligomer
obtain
substitut
rnase
ctermin
loop
compris
residu
shorter
loop
present
onc
devoid
prolin
keyresidu
barnas
binas
rnase
variant
kda
belong
rnase
microbi
superfamili
importantli
firstli
recal
past
mutant
fungal
rnase
shown
acquir
activ
dsrna
upon
dimer
see
tabl
convers
wtrnase
cytotox
unabl
enter
cell
preincorpor
hvj
cellpenetr
envelop
vector
barnas
turn
discov
form
cyclic
domainswap
flowerlik
trimer
adduct
figur
furthermor
barnas
interact
inhibitor
barstar
recent
discov
induc
lysi
staphylococc
bacteria
underlin
barnas
derivat
either
monom
dimer
also
immunopeptid
form
immunornas
deriv
cytotox
breast
ovarian
cancer
binas
instead
variant
known
display
remark
toxic
toward
mani
tumor
cell
also
accompani
relev
antivir
activ
binas
subsequ
found
exist
natur
dimer
presenc
swap
ntermin
domain
strongli
suggest
howev
two
altern
structur
model
confirm
actual
presenc
fact
two
structur
show
electrostat
interact
propos
abl
stabil
interfac
two
monomer
subunit
nativ
binas
dimer
figur
e
interestingli
variant
balifas
also
character
appar
display
lower
cytotox
binas
henc
investig
structur
determin
govern
import
antitumor
activ
microbi
rnase
certainli
deserv
perform
design
futur
efficaci
anticanc
well
antimicrobi
possibl
immunogen
rnase
deriv
sever
aspect
catalyt
immunomodulatori
antitumor
properti
display
mani
rnase
oligomer
deriv
describ
review
result
use
therapi
still
incur
cancer
underlin
suggest
well
although
promis
result
alreadi
obtain
rnase
especi
onc
improv
necessari
term
potenti
cytotox
contemporarili
attenu
delet
undesir
sideeffect
end
rnase
homoor
heterodimer
extens
oligomer
might
certainli
repres
efficaci
strategi
sharpli
tune
heterocrosslink
immunornas
homo
hetero
fusionprotein
certainli
offer
promis
result
could
hope
transfer
toward
clinic
use
next
futur
howev
spontan
artifici
induc
noncoval
rnase
selfassoci
may
also
repres
fruit
pathway
produc
activ
rnase
deriv
henc
oligomer
tendenc
product
form
rnase
bsrnase
rnase
onc
may
suggest
smart
futur
approach
build
complex
chimera
product
report
emerg
determin
drive
rnase
dimer
oligomer
way
make
cytotox
depend
sever
featur
compris
propens
stabil
basic
natur
keyresidu
geometri
supramolecular
adduct
form
featur
affect
crucial
step
correl
cytotox
interact
cell
membran
abil
enter
cytosol
evad
ri
therefor
final
rnase
oligomer
strategi
drive
toward
product
accompani
relev
antitumor
activ
devoid
undesir
sideeffect
moreov
rnase
deriv
character
satisfactori
halflif
circulatori
system
reach
easili
tumor
place
thu
allow
success
applic
therapi
author
contribut
manuscript
gg
structur
function
featur
rnase
oligom
mm
higher
extent
biolog
aspect
relat
activ
rnase
oligom
gg
built
figur
check
overal
english
qualiti
mm
critic
help
make
manuscript
much
coher
homogen
possibl
